Moneycontrol PRO
Upcoming Event:Join us for the exciting discussion with Danone on role of nutrition, protein in working professionals’ quality of life on July 31, 3pm.

Buy Cadila Healthcare: target of Rs 720: Sharekhan

Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 27, 2021.

June 10, 2021 / 11:37 AM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Cadila Healthcare

Cadila Healthcare’s (Cadila) Q4FY2021 numbers were healthy and earnings beat estimates, due to a tax credit and an adjustment for a one-time impairment expenses. Cadila is in a sweet spot, wherein both its geographies, India and the US have an improved growth outlook. Efforts to build a portfolio of Covid drugs including Vaccines augurs well from a growth perspective.


We retain our Buy recommendation on the stock with unchanged PT of Rs. 720

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: May 31, 2021 01:39 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark